Bin Wang
Founder at Beijing Advaccine Biotechnology Co., Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Qing Ling Yu | F | 58 |
Beijing Advaccine Biotechnology Co., Ltd.
 Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 15 years |
| Guan Chun Dai | M | 47 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 3 years |
| Gan Zhao | M | 44 |
China Agricultural University
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 13 years |
| Xiao Yan Liu | M | 40 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 4 years |
| Wen Wei Tu | M | 57 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 3 years |
| Guo Hao Jin | M | 35 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 3 years |
| Jian Qun Peng | F | 39 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 4 years |
| Lu Nan Zhang | F | 36 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 7 years |
| Zhi Yun Yu | M | 45 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 4 years |
| De Cheng Wang | M | 59 |
China Agricultural University
| 16 years |
| Wai Ching Au | F | - |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | - |
| Xiang Yi Xu | M | 68 |
Shandong University
| 42 years |
| Jiang Yu | M | 64 |
Xinjiang University
| 23 years |
| Xue Qin Wu | F | 51 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 4 years |
| Qing Chang | M | 57 |
China Agricultural University
| 19 years |
| Min Ge | M | 55 |
China Agricultural University
| 20 years |
| Ji Ma | M | 62 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | - |
| Zhou Lu | F | 52 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 12 years |
| Sidong Xiong | M | 61 |
Shanghai Medical College of Fudan University
| - |
| Ai Hua Dong | F | 57 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 9 years |
| Dan Liu | M | 50 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 4 years |
| Hong Qin | F | 57 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 3 years |
| Richard C. Levy | M | 77 |
University of Cincinnati (Ohio)
| 40 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Chun Hua Lai | F | 42 |
China Agricultural University
| 7 years |
| Karl J. Grafe | M | - |
University of Cincinnati (Ohio)
| 7 years |
| Brian S. Sullivan | M | - |
University of Cincinnati (Ohio)
| 7 years |
| Bruno Patrick Riboni | M | - |
University of Cincinnati (Ohio)
| 6 years |
| Liang Shi | M | 39 |
China Agricultural University
| 6 years |
| Lang Liu | M | 61 |
China Agricultural University
| 3 years |
| Don Harrison | M | 90 |
University of Cincinnati (Ohio)
| 17 years |
| An Xiang Chen | M | 61 |
Shandong University
| 4 years |
| Daniel Miller | M | - |
University of Cincinnati (Ohio)
| 3 years |
| Timothy C. Toft | M | - |
University of Cincinnati (Ohio)
| 4 years |
| Thomas M. Lampe | M | - |
University of Cincinnati (Ohio)
| 4 years |
| Edward Lehner | M | 58 |
University of Cincinnati (Ohio)
| 4 years |
| Kim K. Bresler | F | - |
University of Cincinnati (Ohio)
| 4 years |
| Rob Jung | M | 61 |
University of Cincinnati (Ohio)
| 3 years |
| Shu Bao Sun | M | 61 |
China Agricultural University
| 4 years |
| Yu Min Sui | M | 60 |
Shandong University
| 4 years |
| Ji Ming Hao | M | 78 |
University of Cincinnati (Ohio)
| 3 years |
| Carter F. Randolph | M | 68 |
University of Cincinnati (Ohio)
| 3 years |
| Ming Fang | M | 66 |
Shandong University
| 4 years |
| Shu Chen Hao | M | 60 |
Shandong University
| 4 years |
| Shao Hua Pei | M | 61 |
Shandong University
| 4 years |
| Wade Keith Daniel | M | - |
University of Cincinnati (Ohio)
| 4 years |
| Li Ming Fan | F | 66 |
Shandong University
| 4 years |
| De Gui Tan | M | 59 |
Shandong University
| 4 years |
| Ming Jun Wang | M | 62 |
Shandong University
| 4 years |
| Mary Dittmar | M | - |
University of Cincinnati (Ohio)
| 4 years |
| Douglas J. Walouke | M | - |
University of Cincinnati (Ohio)
| 4 years |
| Cynthia Isgrig | F | - |
University of Cincinnati (Ohio)
| 4 years |
| Li Ming Jiang | F | 62 |
Shandong University
| 4 years |
| Mitsuo Aoshima | M | 61 |
Shandong University
| 4 years |
| Ling Fang Wang | M | 67 |
Shandong University
| 4 years |
| Jon J. Hemmer | M | - |
University of Cincinnati (Ohio)
| 4 years |
| Jisong Cui | M | 62 |
Shandong University
| 4 years |
| Julie T. Thomas | F | - |
University of Cincinnati (Ohio)
| 3 years |
| Daniel Edward Souders | M | - |
University of Cincinnati (Ohio)
| 4 years |
| Ken Patel | M | - |
University of Cincinnati (Ohio)
| 3 years |
| Da Peng Li | M | 68 |
University of Cincinnati (Ohio)
| 4 years |
| Yun Wei Zhang | M | 59 |
Shandong University
| 4 years |
| Walter Zhao | M | 60 |
Shandong University
| 4 years |
| Wei Xing Wang | M | 60 |
Shandong University
| 4 years |
| Pei Yuan Lin | M | - |
University of Cincinnati (Ohio)
| 3 years |
| John Berding | M | 61 |
University of Cincinnati (Ohio)
| 4 years |
| Pi Shu Sun | M | 61 |
Shandong University
| 4 years |
| David Schaller | M | - |
University of Cincinnati (Ohio)
| 5 years |
| Steven Soloria | M | 58 |
University of Cincinnati (Ohio)
| 4 years |
| Gao Ning Ning | M | 66 |
Shandong University
| 4 years |
| Fred Brink | M | - |
University of Cincinnati (Ohio)
| 5 years |
| Jay Wertz | M | - |
University of Cincinnati (Ohio)
| 4 years |
| Scott Keller | M | - |
University of Cincinnati (Ohio)
| 4 years |
| Timothy E. Kremchek | M | - |
University of Cincinnati (Ohio)
| 4 years |
| Steve Foster | M | 71 |
University of Cincinnati (Ohio)
| 2 years |
| Ken Schlachter | M | 62 |
University of Cincinnati (Ohio)
| 4 years |
| Gregory J. Rossmann | M | 62 |
University of Cincinnati (Ohio)
| 4 years |
| Scott H. Dooley | M | - |
University of Cincinnati (Ohio)
| 4 years |
| Kirk F. Mentzer | M | - |
University of Cincinnati (Ohio)
| 4 years |
| Ying Yan | F | 58 |
Shandong University
| 4 years |
| Mark Louis Friedman | M | 66 |
University of Cincinnati (Ohio)
| 3 years |
| Katherine Blackburn | F | 58 |
University of Cincinnati (Ohio)
| 4 years |
| Lisa Wintersheimer Michel | F | - |
University of Cincinnati (Ohio)
| 3 years |
| Jun Bao | M | 58 |
Shandong University
| 4 years |
| Greg S. Elmlinger | M | - |
University of Cincinnati (Ohio)
| 5 years |
| Adonis Anthony Caneris | M | - |
University of Cincinnati (Ohio)
| 4 years |
| Jian Nong Qian | M | 62 |
Shandong University
| 4 years |
| Randy Vuksta | M | - |
University of Cincinnati (Ohio)
| 4 years |
| Glenn D. Warden | M | - |
University of Cincinnati (Ohio)
| - |
| Mark R. Siwik | M | - |
University of Cincinnati (Ohio)
| 3 years |
| Kimberly Sheehy | F | 59 |
University of Cincinnati (Ohio)
| 4 years |
| Kristine Funk | F | - |
University of Cincinnati (Ohio)
| 2 years |
| Ke Ping Du | M | 62 |
Shandong University
| 4 years |
| Venkat Srinivasan | M | - |
University of Cincinnati (Ohio)
| 3 years |
| Jonathan Dunay | M | - |
University of Cincinnati (Ohio)
| 4 years |
| Thomas W. Heintz | M | - |
University of Cincinnati (Ohio)
| 4 years |
| Chandler Rohal | M | - |
University of Cincinnati (Ohio)
| 4 years |
| Robert E. Noll | M | - |
University of Cincinnati (Ohio)
| 4 years |
| Jim Hendricks | M | - |
University of Cincinnati (Ohio)
| 4 years |
| T. Jeffrey Dowdle | M | - |
University of Cincinnati (Ohio)
| 4 years |
| Qing Jun Wu | M | 59 |
Shandong University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 52 | 52.00% |
| China | 48 | 48.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Bin Wang
- Personal Network
